Drug Reaction with Eosinophilia and Systemic Symptoms Secondary to Naproxen: A Case Report and Literature Review

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe adverse drug reaction presenting with rash, fever, lymphadenopathy, and single or multiple organ involvement. It is most commonly associated with antiepileptics, NSAIDs, and sulfa drugs. We report a 40-year-old man who presented with a 1-week history of fever, sore throat, and a diffuse pruritic macular rash that started on the face and trunk before spreading to all extremities 4 weeks after the use of naproxen. He had lymphadenopathy, hepatosplenomegaly, transaminitis, and peripheral eosinophilia. A Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) score of 8 gave a diagnosis of definite DRESS syndrome. Significant resolution of symptoms and laboratory abnormalities were seen after 2 weeks of corticosteroid therapy. DRESS syndrome is a life-threatening condition, and the clinical status of patients can worsen rapidly. Given the high variability in clinical presentation, the diagnosis of DRESS syndrome requires a high degree of suspicion and clinical judgment. Case reports on this entity will equip physicians in acute medicine to recognize and treat the condition early. This report reinforces the importance of using the RegiSCAR score in the diagnosis of DRESS syndrome.

[1]  C. Sukasem,et al.  Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population , 2017, Pharmacogenetics and genomics.

[2]  A. Pannu,et al.  Diagnostic criteria for drug rash and eosinophilia with systemic symptoms , 2017, Journal of family medicine and primary care.

[3]  D. Naisbitt,et al.  Drug‐specific CD4+ T‐cell immune responses are responsible for antituberculosis drug‐induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome , 2017, The British journal of dermatology.

[4]  C. Strong,et al.  Liver injury in patients with DRESS: A clinical study of 72 cases. , 2015, Journal of the American Academy of Dermatology.

[5]  W. Chung,et al.  Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS) , 2014, The British journal of dermatology.

[6]  L. Naldi,et al.  Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study , 2013, The British journal of dermatology.

[7]  R. Okuyama,et al.  Clinical course of drug‐induced hypersensitivity syndrome treated without systemic corticosteroids , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  R. Schwartz,et al.  DRESS syndrome: Part I. Clinical perspectives. , 2013, Journal of the American Academy of Dermatology.

[9]  C. Chu,et al.  Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. , 2010, Archives of dermatology.

[10]  M. Mockenhaupt,et al.  Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2007, The British journal of dermatology.

[11]  T. Shiohara,et al.  Several herpesviruses can reactivate in a severe drug‐induced multiorgan reaction in the same sequential order as in graft‐versus‐host disease , 2006, The British journal of dermatology.

[12]  Yuan-Tsong Chen,et al.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Thiers HLA-B*5801 Allele as a Genetic Marker for Severe Cutaneous Adverse Reactions Caused by Allopurinol , 2006 .